Drugs / Ubiquinol
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02348125 | Mar 2016 → Jun 2017 | autism spectrum disorder, mitochondrial disease | Drexel University | Unknown | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT06555575 | Jan 2025 → Sep 2026 expected | — | Trio Fertility | Recruiting | No outcome recorded |
| Phase 2 | NCT03133793 | Feb 2018 → Mar 2021 | diastolic heart failure | University of Kansas Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT02934555 | Mar 2016 → May 2019 | cardiac arrest | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT01948063 | Oct 2012 → Apr 2014 | infectious disease with sepsis | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02865460 | Jul 2017 → Oct 2020 | myalgic encephalomeyelitis/chronic fatigue syndrome, persian gulf syndrome | VA Office of Research and Development | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02779634 Comparator | Jul 2016 → Jan 2018 | heart failure | Hadassah Medical Organization | Unknown | No outcome recorded |
| Phase 2 | NCT03061513 Comparator | Feb 2012 → Dec 2016 | Parkinson disease | Weill Medical College of Cornell University | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04870502 Comparator | Apr 2019 → Jul 2020 | polycystic ovary syndrome | Saudi German Hospital - Madinah | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ubiquinol | “Ubiquinol, the reduced form of CoQ10, is more effective in adults over the age of 50.” PMID 29606104 ↗ Apr 20188“* ubiquinol (liquid form, 150 mg/kg subject weight/day” NCT02348125 ↗ |
| Known as | Coenzyme Q10 | “Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock” PMID 26130237 ↗ Jul 20151“Ubiquinol (active form of Coenzyme Q10)” NCT04870502 ↗ |
| Route | Oral | “with the administration of oral ubiquinol” PMID 26130237 ↗ Jul 2015 |